🌟 Acalulxen 100 mg (Acalabrutinib) – Everest Pharma

Acalulxen 100 mg is an advanced oral therapy formulated with Acalabrutinib, a next-generation Bruton's tyrosine kinase (BTK) inhibitor. This targeted treatment is designed to provide precision therapy for patients with certain hematologic malignancies, helping to disrupt cancer cell growth while minimizing damage to healthy cells.

💊 Composition

Each capsule contains:
👉 Acalabrutinib 100 mg

⚡ Indications

Acalulxen 100 mg is indicated for the treatment of:

• Chronic Lymphocytic Leukemia (CLL)

• Small Lymphocytic Lymphoma (SLL)

• Mantle Cell Lymphoma (MCL) (in patients who have received at least one prior therapy)

📌 Key Features

✅ Selective BTK inhibition for targeted cancer control
✅ Designed to minimize off-target effects
✅ Convenient oral capsule formulation
✅ Manufactured under stringent quality standards by Everest Pharma, a trusted name in affordable oncology solutions

🕒 Dosage & Administration

• Standard dosing: 100 mg taken twice daily, approximately 12 hours apart

• Should be taken at the same times each day for best results

• Can be taken with or without food

🏭 Manufacturer

Everest Pharmaceuticals Ltd.
A leading pharmaceutical company dedicated to providing high-quality and affordable cancer treatments to patients worldwide.

🚀 Why Choose Acalulxen?

Acalulxen 100 mg offers hope and advanced therapeutic support for patients fighting blood cancers. With its precise mechanism of action and proven efficacy, it helps clinicians deliver better outcomes while supporting patient quality of life.